Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 108 matching records.
108 results — page 1 of 5
- Level DLaboratory StudyPubMed
Wharton's jelly mesenchymal stem cell-secretome enhances skin rejuvenation via ApoA4 and SERPINH1.
Laboratory Study with a reported sample of 21 on Skin Aging, Chronic Inflammation, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 21
Regen Ther - Level DLaboratory StudyEurope PMC
Comparing the growth kinetics and characteristics of Wharton's jelly derived mesenchymal stem cells expanded using different culture mediums
Laboratory Study on Immune Modulation, published in Cytotechnology (2025) — summary generated from the PubMed abstract.
- 2025
Cytotechnology2 citations - Level BClinical TrialEurope PMC
Consecutive intrabronchial administration of Wharton's jelly-derived mesenchymal stromal cells in ECMO-supported pediatric patients with end-stage interstitial lung disease: a safety and feasibility study (CIBA method)
Clinical Trial on Face & Skin, Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level DLaboratory StudyEurope PMC
Evaluation of the Interaction Between Wharton's Jelly-Derived Mesenchymal Stem Cells and β-Mercaptoethanol
Laboratory Study on Spinal Cord Injury, Neuroinflammation, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus2 citations - Level DLaboratory StudyPubMed
Enhancing adipogenesis in Wharton's jelly multipotent mesenchymal stromal cells through lipidomic insights and fatty acid supplementation.
Laboratory Study, published in Sci Rep (2025) — summary generated from the PubMed abstract.
- 2025
Sci Rep - Level BClinical TrialEurope PMC
The transforming role of wharton's jelly mesenchymal stem cell-derived exosomes for diabetic foot ulcer healing: a randomized controlled clinical trial
Clinical Trial with a reported sample of 53 on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 53
Stem Cell Res Ther5 citations - Level DLaboratory StudyPubMed
Therapeutic Potential and Comparison of the Effects of Mummy on Mesenchymal Stem Cells Derived from Wharton's Jelly and Adipose Tissue Cultured with Human Fibroblasts.
Laboratory Study on Chronic Wound, Scar, published in Int J Hematol Oncol Stem Cell Res (2025) — summary generated from the PubMed abstract.
- 2025
Int J Hematol Oncol Stem Cell Res - Level DLaboratory StudyPubMed
Enhancing insulin sensitivity in type 2 diabetes mellitus using apelin-loaded small extracellular vesicles from Wharton's jelly-derived mesenchymal stem cells: a novel therapeutic approach.
Laboratory Study on Type 2 Diabetes, Chronic Inflammation, published in Diabetol Metab Syndr (2024) — summary generated from the PubMed abstract.
- 2024
Diabetol Metab Syndr - Level CProspective StudyPubMed
Exosomes Secreted by Wharton's Jelly-Derived Mesenchymal Stem Cells Promote the Ability of Cell Proliferation and Migration for Keratinocyte.
Prospective Study on Chronic Wound, Immune Modulation, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci - Level DNarrative ReviewEurope PMC
Wharton's jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury
Narrative Review, published in World J Stem Cells (2024) — summary generated from the PubMed abstract.
- 2024
World J Stem Cells12 citations - Level DLaboratory StudyEurope PMC
Genipin cross-linked gelatin hydrogel for encapsulating wharton jelly mesenchymal stem cells and basic fibroblast growth factor delivery in vocal fold regeneration
Laboratory Study, published in Front Cell Dev Biol (2024) — summary generated from the PubMed abstract.
- 2024
Front Cell Dev Biol6 citations - Level DAnimal StudyPubMed
Reversal of Pulmonary Fibrosis: Human Umbilical Mesenchymal Stem Cells from Wharton's Jelly versus Human-Adipose-Derived Mesenchymal Stem Cells.
Animal Study, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci11 citations - Level DLaboratory StudyEurope PMC
Cytochalasin B Influences Cytoskeletal Organization and Osteogenic Potential of Human Wharton's Jelly Mesenchymal Stem Cells
Laboratory Study, published in Pharmaceuticals (Basel) (2023) — summary generated from the PubMed abstract.
- 2023
Pharmaceuticals (Basel)11 citations - Level DAnimal StudyEurope PMC
In vitro and in vivo evaluation of electrospun poly (ε-caprolactone)/collagen scaffolds and Wharton's jelly mesenchymal stromal cells (hWJ-MSCs) constructs as potential alternative for skin tissue engineering
Animal Study on Face & Skin, published in Regen Ther (2023) — summary generated from the PubMed abstract.
- 2023
Regen Ther12 citations - Level DLaboratory StudyPubMed
Expression Profile of New Marker Genes Involved in Differentiation of Human Wharton's Jelly-Derived Mesenchymal Stem Cells into Chondrocytes, Osteoblasts, Adipocytes and Neural-like Cells.
Laboratory Study on Immune Modulation, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci - Level DLaboratory StudyPubMed
Comparative Analysis of Porcine Adipose- and Wharton's Jelly-Derived Mesenchymal Stem Cells.
Laboratory Study, published in Animals (Basel) (2023) — summary generated from the PubMed abstract.
- 2023
Animals (Basel)7 citations - Level BClinical TrialEurope PMC
Feline Wharton's jelly-derived mesenchymal stem cells as a feeder layer for oocytes maturation and embryos culture in vitro
Clinical Trial, published in Front Vet Sci (2023) — summary generated from the PubMed abstract.
- 2023
Front Vet Sci1 citations - Level DAnimal StudyEurope PMC
Human Wharton's jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment
Animal Study on Systemic / IV, published in J Transl Med (2023) — summary generated from the PubMed abstract.
- 2023
J Transl Med5 citations - Level BClinical TrialEurope PMC
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Clinical Trial on Face & Skin, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther22 citations - Level BClinical TrialEurope PMC
Suitability of Human Mesenchymal Stem Cells Derived from Fetal Umbilical Cord (Wharton's Jelly) as an Alternative In Vitro Model for Acute Drug Toxicity Screening
Clinical Trial, published in Cells (2022) — summary generated from the PubMed abstract.
- 2022
Cells12 citations - Level DLaboratory StudyPubMed
Comparison Study on the Effect of Mesenchymal Stem Cells-Conditioned Medium Derived from Adipose and Wharton's Jelly on Versican Gene Expression in Hypoxia.
Laboratory Study on Face & Skin, published in Iran Biomed J (2022) — summary generated from the PubMed abstract.
- 2022
Iran Biomed J - Level DAnimal StudyEurope PMC
The therapeutic potential of Camel Wharton jelly mesenchymal stem cells (CWJ-MSCs) in canine chronic kidney disease model
Animal Study on Chronic Kidney Disease, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
Stem Cell Res Ther2 citations - Level CProspective StudyPubMed
Shipping Temperature, Time and Media Effects on Equine Wharton's Jelly and Adipose Tissue Derived Mesenchymal Stromal Cells Characteristics.
Prospective Study on Hip, published in Animals (Basel) (2022) — summary generated from the PubMed abstract.
- 2022
Animals (Basel) - Level BClinical TrialEurope PMC
Human Wharton's Jelly-derived mesenchymal stem cells prevent acetaminophen-induced liver injury in a mouse model unlike human dermal fibroblasts
Clinical Trial, published in Arch Toxicol (2022) — summary generated from the PubMed abstract.
- 2022
Arch Toxicol14 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406